Trial Profile
Clinical study evaluating efficacy of Nilotinib in CML patients.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Feb 2012
Price :
$35
*
At a glance
- Drugs Nilotinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 06 Oct 2009 New trial record